3858 results for «2278»
3858 results
Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
Featured Cases - TAVI in patients with challenging vascular access
24 Nov 2024 – From PCR London Valves 2024
Delve into a collection of captivating TAVI cases that push the boundaries of vascular access challenges. Witness how interventionists navigate complex aortic anatomies, dissections, and rare genetic diseases to deliver life-saving care. Explore innovative approaches such as transbrachial TAVI, transcarotid access, and valve-in-valve TAVI. This session...
Pushing the boundaries to optimise patient outcomes: from planning to success
26 Nov 2024 – From PCR London Valves 2024
Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
Featured cases - Challenging tricuspid interventions (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of featured cases showcasing the latest advances in transcatheter tricuspid valve interventions. Witness groundbreaking techniques, including the first TTVR designed to reduce afterload mismatch, the management of atrial embolization, and the use of intracardiac echocardiography. Explore complex anatomies, failed prior...
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
Rapid-fire - Transcatheter solutions for rare complications
24 Nov 2024 – From PCR London Valves 2024
Prepare to be captivated by a rapid-fire session showcasing transcatheter solutions for rare and complex cardiovascular complications. Witness the percutaneous closure of a right ventricular pseudo-aneurysm, the treatment of a VSD complicating myocardial infarction, and the management of iatrogenic left ventricular pseudo-aneurysms. Explore innovative approaches to...
Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice
24 Nov 2024 – From PCR London Valves 2024
Is early TAVI the right choice for your asymptomatic patients with severe aortic stenosis? In this video, we break down the latest clinical trials, including EARLY TAVR and EVOLVED, to help you navigate the complex decision-making process.
Find out what these studies really tell us about the...
Featured research - Aortic valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.
TAVI innovations: late-breaking trials from PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
What does the future hold for TAVI procedures? Don’t miss the latest innovations—watch this video now! It explores the Late-Breaking Trials from PCR London Valves 2024, featuring groundbreaking studies that could transform the way we approach TAVI in clinical practice.
You’ll dive into the CANNULATE TAVR EXTENDED...
Featured cases - Mitral valve-in-valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a collection of captivating clinical cases focused on mitral valve-in-valve procedures. Learn from experienced practitioners as they share their approaches to addressing complex challenges, such as paravalvular leaks, difficult anatomies, and innovative techniques.
Featured research - Aortic valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.
Featured research - Tricuspid valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore the latest research on tricuspid valve interventions in this featured session from PCR London Valves 2024. Discover insights on the prognostic impact of heart failure hospitalization in severe tricuspid regurgitation, the influence of moderate mitral regurgitation in tricuspid TEER patients, the association of effective right...
Featured cases - Strategic approaches in mitral regurgitation
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in this featured session showcasing strategic approaches in the management of mitral regurgitation. Explore a range of complex cases, including percutaneous annuloplasty with a novel device in functional mitral regurgitation, the management of mitral annulus cavity and regurgitation post-healed endocarditis, simultaneous management of two...
TAVI in bicuspid anatomy
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the key insights from this PCR Tokyo Valves 2025 session focused on TAVI in bicuspid anatomy. Learn why TAVI for bicuspid aortic stenosis (AS) shows comparable long-term outcomes to tricuspid AS in registry data, and understand the importance of patient selection, precise valve sizing, and...
M-TEER for primary mitral regurgitation
08 Feb 2025 – From PCR Tokyo Valves 2025
In this PCR Tokyo Valves 2025 session on M-TEER for primary mitral regurgitation, gain valuable insights starting with an overview of current TEER devices. Benefit from four case studies that highlight the features of these devices, explore strategies to prevent mitral regurgitation recurrence post-TEER, and delve...
M-TEER around the world
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore the latest insights and advancements in the field of Mitral Transcatheter Edge-to-Edge Repair (M-TEER) from around the world. Discover a new anatomical risk score for predicting procedural outcomes, two-year outcomes from the MiCLASP study, the impact of regurgitant volume to left atrial volume ratio on...
